EU, India to collaborate on ‘peaceful uses’ of nuclear energy under Euratom deal

EU–India Euratom Nuclear Energy Collaboration

UPSC Prelims + Mains Study Note

1. At a Glance

• India and the EU formalised R&D cooperation on the peaceful uses of nuclear energy through an agreement with Euratom (European Atomic Energy Community) signed in July 2020. [1]
• The collaboration was reaffirmed and expanded at the 16th EU–India Summit (New Delhi, 27 January 2026) under the Joint India-EU Comprehensive Strategic Agenda. [2][3]
• Scope spans nuclear science, radiation safety, nuclear security, radio-pharmaceuticals, advanced materials, and cooperation on ITER (International Thermonuclear Experimental Reactor). [2]
• UPSC relevance: GS-II (India's bilateral/multilateral relations), GS-III (energy security, nuclear technology, science & technology).

2. Why in the News

• The Joint India-EU Comprehensive Strategic Agenda statement released on 28 January 2026 specifically highlighted Euratom cooperation as a pillar of future collaboration. [2]
• The 16th EU–India Summit (27 January 2026, New Delhi) endorsed the Joint Strategic Agenda 2030, broadening and deepening the bilateral relationship—Euratom nuclear cooperation was a named deliverable. [3]
• Present at the New Delhi meeting: Union Minister Piyush Goyal and NSA Ajit Doval with EU delegates. [2]

3. Background & Evolution

• Predecessor: India's civil nuclear cooperation gained international legitimacy after the India–US Civil Nuclear Deal (2008) and the NSG waiver (2008), opening doors to bilateral nuclear R&D agreements with other blocs.

4. Core Static Facts

Euratom

• Full name: European Atomic Energy Community (Euratom)
• Established by: Treaty of Rome, 1957 (same day as EEC Treaty)
• Purpose: Coordinate nuclear energy research, ensure safe supply, civilian use only; not a defence body
• Governed separately from the EU but shares institutions (European Commission, Council, Parliament)

The India–Euratom Agreement (2020)

• Type: R&D Cooperation Agreement (not a fuel-supply or reprocessing deal)
• Signed: July 2020
• Scope (as per 2026 Joint Agenda statement): [2]
• Nuclear science & technology
• Advanced materials for detectors
• Radiation safety
• Nuclear security
• Non-power applications of atomic energy (including radio-pharmaceuticals)
• Cooperation in ITER

ITER

• Full form: International Thermonuclear Experimental Reactor
• Location: Cadarache, France
• Members (7 parties): EU (via Euratom), India, China, Japan, South Korea, Russia, USA
• India joined ITER Agreement: 2006 [4]
• India's nodal agency for ITER: Institute for Plasma Research (IPR), Gandhinagar, under Department of Atomic Energy (DAE)
• India's contribution: manufactures key components (~9% of total construction value)

Horizon Europe

• EU's key funding programme for research and innovation
• Duration: 2021–2027
• India's participation: through co-funding and coordinated calls [2][5]
• Sectors of India–EU Horizon Europe focus: energy, water, agri-food, health, semiconductors, biotech, advanced materials

Key Indian Institutions

• Department of Atomic Energy (DAE) — nodal ministry for nuclear cooperation
• Atomic Energy Commission (AEC) — policy body
• BARC (Bhabha Atomic Research Centre) — R&D; relevant for radio-pharmaceuticals
• NPCIL — nuclear power; not directly covered by this R&D agreement

5. Multi-Dimensional Analysis

Geopolitical / Strategic

• The Euratom deal signals India's deepening integration with Western multilateral science regimes without compromising strategic autonomy on the NPT question (India is not an NPT signatory). [1]
• Reaffirmation at the 16th EU–India Summit coincides with India's growing pivot toward Comprehensive Strategic Partnerships with major blocs (also has CSPs with France, Germany individually). [3]
• ITER participation places India at the table of next-generation fusion energy diplomacy alongside all major powers. [4]
• The parallel CBAM dispute (Carbon Border Adjustment Mechanism on steel/iron) shows EU–India cooperation is multi-layered—nuclear cooperation is insulated from trade friction. [2]

Scientific / Technological

• Radio-pharmaceutical cooperation (non-power nuclear application) has direct implications for nuclear medicine — cancer diagnostics and therapy (e.g., Mo-99, Tc-99m supply chains). [2]
• ITER fusion represents a qualitative leap beyond fission: if successful, it provides near-limitless, low-carbon baseload energy; India's component manufacturing expertise advances domestic fusion R&D. [4]
• Cooperation on advanced materials for detectors supports both civilian nuclear safety and scientific instrumentation (particle physics, medical imaging).
• Horizon Europe linkage allows Indian researchers access to EU grant mechanisms — critical for semiconductor and biotech R&D ecosystems. [5]

Economic

• India's energy security demands diversification: nuclear power is targeted at ~22.5 GW installed capacity by 2031 (per DAE roadmap); EU technical collaboration accelerates this.
• CBAM — a parallel economic tension — imposes carbon costs on Indian steel/iron exporters to the EU; decoupled from nuclear cooperation but shapes the broader bilateral negotiation context. [2]
• Horizon Europe co-funding mechanisms reduce India's R&D expenditure burden in frontier technologies.

Environmental

• Nuclear energy (both fission and fusion) is a low-carbon energy source critical for meeting India's net-zero by 2070 and 500 GW non-fossil target by 2030 commitments under NDCs. [5]
• ITER's fusion success would eliminate the long-lived radioactive waste problem of conventional fission plants.
• Radiation safety cooperation helps India meet IAEA safety standards for expanded reactor fleet.

Legal / Constitutional

• India's nuclear sector is governed by the Atomic Energy Act, 1962 — places all atomic energy activities under Central Government; private sector excluded from fuel cycle.
• Atomic Energy (Amendment) Act, 2010 allowed joint ventures between NPCIL and PSUs.
• The Euratom R&D agreement falls under executive (treaty-making) power of the Union; does not require parliamentary ratification under Indian law (Article 253 + Entry 14, Union List).
• India is not a signatory to the NPT — Euratom agreements are structured as science/R&D deals, carefully avoiding fuel-supply/reprocessing terms that would trigger NPT compliance questions.

6. Recent Developments (Last 12–18 Months)

• 27 January 2026: 16th EU–India Summit, New Delhi — Joint Strategic Agenda 2030 endorsed; Euratom nuclear collaboration reaffirmed as a named deliverable. [3]
• 28 January 2026: Official release of the Joint India-EU Comprehensive Strategic Agenda statement detailing cooperation areas under the Euratom agreement. [2]
• 2025: EU–India Free Trade Agreement (FTA) negotiations resumed — CBAM remains a major sticking point for iron/steel sectors. [2]
• Ongoing: India's ITER contributions — cryostat, magnet feeders, cooling water systems — under fabrication at domestic facilities; ITER first plasma target remains 2025–2027 timeframe (delayed from earlier schedules). [4]
• Horizon Europe 2025 calls: India–EU coordinated research calls in semiconductors and advanced materials continued under bilateral science & technology agreement. [5]

7. Prelims Hooks

1. Euratom was established by the Treaty of Rome, 1957 — the same treaty that created the European Economic Community (EEC). [1]
2. India signed the R&D Agreement on Peaceful Uses of Nuclear Energy with Euratom in July 2020. [1]
3. ITER stands for International Thermonuclear Experimental Reactor and is located at Cadarache, France. [4]
4. ITER has 7 member parties: EU (Euratom), India, China, Japan, South Korea, Russia, and the USA — India joined in 2006. [4]
5. India's nodal agency for ITER is the Institute for Plasma Research (IPR), Gandhinagar, under the Department of Atomic Energy. [4]
6. The 16th EU–India Summit was held in New Delhi on 27 January 2026 and endorsed the Joint Strategic Agenda 2030. [3]
7. Horizon Europe is the EU's key funding programme for research; it covers the period 2021–2027. [5]
8. The India–Euratom agreement covers non-power applications of atomic energy, including radio-pharmaceuticals — relevant for cancer diagnostics/therapy. [2]
9. CBAM (Carbon Border Adjustment Mechanism) — EU's mechanism imposing additional tariffs on carbon-intensive imports (iron/steel) from outside the EU — is a separate bilateral irritant in EU–India relations. [2]
10. The Atomic Energy Act, 1962 is the primary legislation governing India's nuclear sector; it excludes the private sector from the fuel cycle. [S2 — contextual]
11. India is a non-NPT state — Euratom R&D agreements with India are structured as science cooperation deals to avoid NPT compliance requirements. [1]
12. NSA Ajit Doval and Union Minister Piyush Goyal represented India at the January 2026 EU–India discussions where the Euratom deal was reaffirmed. [2]
13. Radiation safety and nuclear security (not just power generation) are explicit pillars of the India–Euratom agreement. [2]

8. Mains Relevance

GS Paper(s):

• GS-II: India's bilateral/multilateral relations; International institutions and groupings; India and its relations with major powers (EU).
• GS-III: Energy security; Nuclear energy; Science & technology — developments and their applications; Awareness in the fields of IT, Space, Computers, Robotics, Nanotechnology, Biotechnology.

Syllabus Headings:

• Bilateral, regional and global groupings and agreements involving India (GS-II)
• Indian Economy — energy security (GS-III)
• Science & technology — nuclear, fusion energy (GS-III)

Plausible Mains Questions:

1. "The India–Euratom R&D agreement of 2020 represents a qualitative shift in India's nuclear diplomacy. Examine its strategic significance and the challenges that remain." (GS-II/GS-III, 15 marks)
2. "ITER represents both a scientific milestone and a geopolitical statement. Critically analyse India's role in the ITER project and its implications for India's energy future." (GS-III, 15 marks)
3. "Assess the significance of the India–EU Comprehensive Strategic Agenda 2030 with special reference to nuclear energy and R&D cooperation. How does it square with India's status as a non-NPT state?" (GS-II, 10 marks)

9. Related Topics to Study Next

10. Common Errors / Trap Areas

1. Euratom ≠ EU: Euratom is a separate legal entity established by a distinct treaty (Treaty of Rome, 1957); it shares EU institutions but is not the EU itself. Do not write "the EU's nuclear energy body" without qualification.
2. ITER = fusion, not fission: ITER is a thermonuclear fusion experimental reactor — not a fission power plant. Confusing the two is a frequent MCQ trap.
3. India joined ITER in 2006, not later: Some aspirants conflate India's ITER membership year with later amendments or the 2020 Euratom agreement. These are separate milestones.
4. The 2020 agreement is R&D only, not fuel supply: The India–Euratom agreement is restricted to research and development; it does not involve nuclear fuel supply, reprocessing, or weapons-sensitive technology transfers — the NPT context makes this distinction critical.
5. Implementing ministry is DAE, not MEA alone: While MEA signs treaties, the Department of Atomic Energy (under the Prime Minister's Office) is the implementing authority for nuclear cooperation — not the Ministry of External Affairs or Ministry of Science & Technology.
6. CBAM applies to steel/iron, not nuclear: CBAM is a trade mechanism on carbon-intensive goods (steel, cement, aluminium, etc.) — not related to nuclear imports/exports. Conflating the two issues in the same EU–India context is a common error.